Ebola Drug Poses Question of Ethics in Treatment

As the death toll from the Ebola virus disease continues to soar in several West African countries, an experimental drug called ZMapp was administered to two U.S. missionaries who contracted the virus while working with Ebola patients in Liberia.  The two patients are reportedly doing well in an Atlanta hospital, but a Spanish priest tested positive for the virus in Monrovia may have received the same drug before dying in a Madrid hospital. The drug was developed by a U.S....

© La Voix de l'Amérique - mercredi 20 août 2014